217 related articles for article (PubMed ID: 24338561)
21. Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy.
Palta M; Patel P; Broadwater G; Willett C; Pepek J; Tyler D; Zafar SY; Uronis H; Hurwitz H; White R; Czito B
Ann Surg Oncol; 2012 May; 19(5):1535-40. PubMed ID: 22045467
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience.
Jin Z; Hartgers ML; Sanhueza CT; Shubert CR; Alberts SR; Truty MJ; Muppa P; Nagorney DM; Smyrk TC; Hassan M; Mahipal A
Eur J Surg Oncol; 2018 May; 44(5):677-683. PubMed ID: 29506768
[TBL] [Abstract][Full Text] [Related]
23. Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience.
Hung FC; Kuo CM; Chuah SK; Kuo CH; Chen YS; Lu SN; Chang Chien CS
J Gastroenterol Hepatol; 2007 May; 22(5):724-8. PubMed ID: 17444863
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant radiotherapy following pancreaticoduodenectomy for ampullary adenocarcinoma improves survival in node-positive patients: a propensity score analysis.
Kamarajah SK
Clin Transl Oncol; 2018 Sep; 20(9):1212-1218. PubMed ID: 29497964
[TBL] [Abstract][Full Text] [Related]
25. Important prognostic factors in adenocarcinoma of the ampulla of Vater.
Lowe MC; Coban I; Adsay NV; Sarmiento JM; Chu CK; Staley CA; Galloway JR; Kooby DA
Am Surg; 2009 Sep; 75(9):754-60; discussion 761. PubMed ID: 19774945
[TBL] [Abstract][Full Text] [Related]
26. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.
Ecker BL; Vollmer CM; Behrman SW; Allegrini V; Aversa J; Ball CG; Barrows CE; Berger AC; Cagigas MN; Christein JD; Dixon E; Fisher WE; Freedman-Weiss M; Guzman-Pruneda F; Hollis RH; House MG; Kent TS; Kowalsky SJ; Malleo G; Salem RR; Salvia R; Schmidt CR; Seykora TF; Zheng R; Zureikat AH; Dickson PV
JAMA Surg; 2019 Aug; 154(8):706-714. PubMed ID: 31141112
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy.
Erdmann JI; Morak MJ; Duivenvoorden HJ; van Dekken H; Kazemier G; Kok NF; van Eijck CH
HPB (Oxford); 2015 Jul; 17(7):573-9. PubMed ID: 25800041
[TBL] [Abstract][Full Text] [Related]
28. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.
Duffy JP; Hines OJ; Liu JH; Ko CY; Cortina G; Isacoff WH; Nguyen H; Leonardi M; Tompkins RK; Reber HA
Arch Surg; 2003 Sep; 138(9):941-8; discussion 948-50. PubMed ID: 12963649
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
30. Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience.
Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2012 Dec; 35(6):533-6. PubMed ID: 21659832
[TBL] [Abstract][Full Text] [Related]
31. Increased number of metastatic lymph nodes in adenocarcinoma of the ampulla of Vater as a prognostic factor: a proposal of new nodal classification.
Kang HJ; Eo SH; Kim SC; Park KM; Lee YJ; Lee SK; Yu E; Cho H; Hong SM
Surgery; 2014 Jan; 155(1):74-84. PubMed ID: 24238122
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
[TBL] [Abstract][Full Text] [Related]
33. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
[TBL] [Abstract][Full Text] [Related]
34. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant therapy for true ampullary cancer: a systematic review.
Bonet M; Rodrigo A; Vázquez S; Carrizo V; Vilardell F; Mira M
Clin Transl Oncol; 2020 Aug; 22(8):1407-1413. PubMed ID: 31927720
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547
[TBL] [Abstract][Full Text] [Related]
37. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma.
Kim RD; Kundhal PS; McGilvray ID; Cattral MS; Taylor B; Langer B; Grant DR; Zogopoulos G; Shah SA; Greig PD; Gallinger S
J Am Coll Surg; 2006 Jan; 202(1):112-9. PubMed ID: 16377504
[TBL] [Abstract][Full Text] [Related]
38. Ampullary adenocarcinoma: Defining predictors of survival and the impact of adjuvant therapy following surgical resection for stage I disease.
Stiles ZE; Behrman SW; Deneve JL; Glazer ES; Dong L; Wan JY; Martin MG; Dickson PV
J Surg Oncol; 2018 Jun; 117(7):1500-1508. PubMed ID: 29518820
[TBL] [Abstract][Full Text] [Related]
39. Carcinoma of the ampulla of Vater: results of surgical treatment of a single center.
Memon MA; Shiwani MH; Anwer S
Hepatogastroenterology; 2004; 51(59):1275-7. PubMed ID: 15362731
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
